| 臺大學術典藏 |
2022-08-19T00:21:08Z |
Predictors of toxicity of weekly docetaxel in chemotherapy-treated non-small cell lung cancers
|
Chen J.-P.; Lo Y.; Yu C.-J.; CHIUN HSU; Shih J.-Y.; Yang C.-H. |
| 臺大學術典藏 |
2022-08-19T00:21:08Z |
A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: A randomized trial
|
Cheng A.-L.; Chen P.-J.; Wu H.-B.; Tien H.-F.; Chao T.-Y.; Liu T.-W.; Li C.-C.; Liao Y.-M.; Chang M.-C.; Young J.-H.; Hsiao H.-H.; Lin T.-H.; Lin S.-F.; Wang M.-C.; Hwang W.-S.; Su I.-J.; CHIUN HSU; Hsiung C.A. |
| 臺大學術典藏 |
2022-08-19T00:21:08Z |
Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment
|
Lin Z.-Z.; CHIUN HSU; Chang Y.-C.; Yu C.-J.; Hsu C.-H.; Lin C.-C.; Cheng A.-L.; Yang P.-C.; Yang C.-H. |
| 臺大學術典藏 |
2022-08-19T00:21:09Z |
Comparison of hypoplastic myelodysplastic syndrome (MDS) with normo-/hypercellular MDS by International Prognostic Scoring System, cytogenetic and genetic studies
|
Huang T.-C.; Ko B.-S.; Tang J.-L.; CHIUN HSU; Chen C.-Y.; Tsay W.; Huang S.-Y.; Yao M.; Chen Y.-C.; Shen M.-C.; Wang C.-H.; Tien H.-F. |
| 臺大學術典藏 |
2022-08-19T00:21:09Z |
Dynamic MRI signals in the second week of radiotherapy relate to treatment outcomes of hepatocellular carcinoma: A preliminary result
|
Liang P.-C.; Ch'ang H.-J.; CHIUN HSU; Tseng S.S.; Shih T.T.F.; Wu Liu T. |
| 臺大學術典藏 |
2022-08-19T00:21:09Z |
Multifractionated paclitaxel and cisplatin combined with 5-fluorouracil and leucovorin in patients with metastatic or recurrent esophageal squamous cell carcinoma
|
Lin C.-C.; Yeh K.-H.; Yang C.-H.; CHIUN HSU; Tsai Y.-C.; Hsu W.-L.; Cheng A.-L.; Hsu C.-H. |
| 臺大學術典藏 |
2022-08-19T00:21:10Z |
A phase II trial of weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in patients with chemotherapy-pretreated metastatic breast cancer
|
Lin C.-C.; Cheng A.-L.; Hsu C.-H.; Lu Y.-S.; CHIUN HSU; Yeh K.-H.; Wu C.-Y.; Huang C.-S.; Yang C.-H. |
| 臺大學術典藏 |
2022-08-19T00:21:10Z |
Survival outcome and predictors of gefitinib antitumor activity in East Asian chemonaive patients with advanced nonsmall cell lung cancer
|
Yang P.-C.; Chang G.-C.; CHIUN HSU; Gow C.-H.; Yang C.-H.; Shih J.-Y.; Chen K.-C.; Yu C.-J.; Yang T.-Y.; Lin C.-P.; Su W.-P. |
| 臺大學術典藏 |
2022-08-19T00:21:10Z |
Expression of the caudal-type homeodomain transcription factor CDX2 is related to clinical outcome in biliary tract carcinoma
|
Chang Y.-T.; CHIUN HSU; Jeng Y.-M.; Chang M.-C.; Wei S.-C.; Wong J.-M. |
| 臺大學術典藏 |
2022-08-19T00:21:11Z |
CD24 expression is a prognostic factor in intrahepatic cholangiocarcinoma
|
Su M.-C.; CHIUN HSU; Kao H.-L.; Jeng Y.-M. |
| 臺大學術典藏 |
2022-08-19T00:21:12Z |
Phase I-II trial of weekly gemcitabine plus high-dose 5-fluorouracil and leucovorin in advanced pancreatic cancer
|
Shiah H.-S.; Cheng A.-L.; CHIUN HSU; Hsu C.-H.; Liu T.-W.; Chang J.-Y.; Jan C.-M.; Chao Y.; Yu W.-L.; Chuang T.-R.; Whang-Peng J.; Chen L.-T. |
| 臺大學術典藏 |
2022-08-19T00:21:12Z |
Phase I study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of fluorouracil/leucovorin for advanced pancreatic cancer
|
Ch'ang H.-J.; Wang C.-C.; Cheng A.-L.; CHIUN HSU; Lu Y.-S.; Chang M.-C.; Lin J.-T.; Wang H.-P.; Shiah H.-S.; Liu T.-W.; Chang J.-Y.; Whang-Peng J.; Chen L.-T. |
| 臺大學術典藏 |
2022-08-19T00:21:13Z |
Unexpected rapid progression of metastatic adenoid cystic carcinoma during treatment with imatinib mesylate
|
Lin C.-H.; Yen R.-F.; Jeng Y.-M.; Tzen C.-Y.; CHIUN HSU; Hong R.-L. |
| 臺大學術典藏 |
2022-08-19T00:21:13Z |
Gefitinib treatment for non-small cell lung cancer - A study including patients with poor performance status
|
Shih J.-Y.; CHIUN HSU; Yang P.-C.; Su W.-P.; Yang C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2022-08-19T00:21:14Z |
Significant difference in the trends of female breast cancer incidence between Taiwanese and Caucasian Americans: Implications from age-period-cohort analysis
|
Shen Y.-C.; Chang C.-J.; CHIUN HSU; Cheng C.-C.; Chiu C.-F.; Cheng A.-L. |
| 臺大學術典藏 |
2022-08-19T00:21:14Z |
Effect of thalidomide in hepatocellular carcinoma: Assessment with power Doppler US and analysis of circulating angiogenic factors
|
CHIUN HSU; Chen C.-N.; Chen L.-T.; Wu C.-Y.; Hsieh F.-J.; Cheng A.-L. |
| 臺大學術典藏 |
2022-08-19T00:21:14Z |
Survival of stage IIIB/IV non-small cell lung cancer patients who received chemotherapy but did not participate in clinical trials
|
CHIUN HSU; Cheng A.-L.; Yang P.-C.; Yu C.-J.; Yang C.-H.; Kuo S.-H. |
| 臺大學術典藏 |
2022-08-19T00:21:15Z |
Lack of efficacy of troglitazone at clinically achievable concentrations, with or without 9-cis retinoic acid or cytotoxic agents, for hepatocellular carcinoma cell lines
|
Shen Y.-C.; CHIUN HSU; Chen J.-Y.; Cheng A.-L. |
| 臺大學術典藏 |
2022-08-19T00:21:15Z |
Recent advances in non-surgical treatment for advanced hepatocellular carcinoma
|
CHIUN HSU; Cheng J.C.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2022-08-19T00:21:15Z |
Quality of life of lung cancer patients: Validation of the Taiwan Chinese version of the EORTC QLQ-C30 and QLQ-LC13
|
Chie W.-C.; Yang C.-H.; CHIUN HSU; Yang P.-C. |
| 臺大學術典藏 |
2022-08-19T00:21:15Z |
Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/ leucovorin for locally advanced or metastatic carcinoma of the biliary tract
|
Cheng A.-L.; Wu C.-Y.; Chen J.-S.; Li C.-C.; Liu H.-T.; Hsu C.-H.; Lu Y.-S.; Yeh K.-H.; Yang C.-H.; Shen Y.-C.; CHIUN HSU |
| 臺大學術典藏 |
2022-08-19T00:21:16Z |
Survival-weighted health profile for long-term survivors of acute myelogenous leukemia
|
Tang J.-L.; Chen Y.-C.; Cheng A.-L.; Chang S.-M.; Tien H.-F.; Hwang J.-S.; Wang J.-D.; CHIUN HSU |
| 臺大學術典藏 |
2022-08-19T00:21:16Z |
Using standardised measures of health-related quality of life: Critical issues for users and developers
|
Kind P.; CHIUN HSU; Wang J.-D.; Yao G.; Tang J.-L. |
| 臺大學術典藏 |
2022-08-19T00:21:16Z |
Phase II trial combining paclitaxel with 24-hour infusion cisplatin for chemotherapy-na?ve patients with locally advanced or metastatic breast carcinoma
|
Cheng A.-L.; Chang K.-J.; Chen M.M.; Lu Y.-S.; Bu C.-F.; CHIUN HSU; Huang C.-S.; Chao T.-Y. |
| 臺大學術典藏 |
2022-08-19T00:21:16Z |
Low-dose thalidomide treatment for advanced hepatocellular carcinoma
|
CHIUN HSU; Chen C.-N.; Chen L.-T.; Wu C.-Y.; Yang P.-M.; Lai M.-Y.; Lee P.-H.; Cheng A.-L. |
